Sjögren’s syndrome in patient with CFTR mutation gene. Case report and review of literature
Journal Title: Reumatologia - Year 2010, Vol 48, Issue 3
Abstract
Sjögren’s syndrome is a systemic, chronic autoimmune disease in which pancreatitis may appear. Here we present 21-year-old woman, with mutation of cystic fibrosis gene, recurrent pancreatitis, leucopenia and hipergammaglobulinemia, which had led to establish diagnosis of primary Sjögren’s syndrome.
Authors and Affiliations
Anna Masiak, Zenobia Czuszyńska, Zbigniew Zdrojewski
Keywords
Related Articles
- EP ID EP85308
- DOI -
- Views 114
- Downloads 0
Predictive factors of cervical spine inflammatory changes and development of instability in patients with rheumatoid arthitis
The aim of the study was verification of some factors deemed to be predictive of inflammation and instability of upper cervical spine in rheumatoid arthritis. 100 patients (88 female and 12 male) aged 23 to 85 (61.4±12.9...
Assessment of skin invovement in patients with systemic sclerosis: practical remarks and clinical relevance
Systemic sclerosis (SSc) is a connective tissue disease characterized by progressive fibrosis of the skin and internal organs. Assessment of skin involvement is of significant importance for establishing patient prognosi...
Ocena przydatności znieczulenia przewodowego do operacji ortopedycznych u chorych z chorobami reumatycznymi
Celem pracy było przedstawienie roli i przydatności znieczulenia przewodowego u pacjentów poddanych zabiegom ortopedycznym. Analizą objęto 719 pacjentów z reumatoidalnym zapaleniem stawów lub chorobą zwyrodnieniową, u...
Juvenile psoriatic arthritis - a case report
An 11-year case history of a patient aged 24 with spondylitis intractu juvenile psoriatic arthritis. The clinical picture, diagnostic problem and disease out come are described.
The value of the assessment of interleukin-6 (IL-6), matrix metalloproteinases and their inhibitors in serum in the assessment of rheumatoid arthritis activity
The aim of the study was to explore whether the serum level of interleukin 6 (IL-6) is correlated with matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), and with clinical markers of th...